RT20 | Retatrutide 20mg Research Peptide | Level Pep

RT20 | Retatrutide 20mg

For Research Purposes Only.

Retatrutide is a triple incretin receptor agonist (GIP, GLP-1, and glucagon) under active investigation in metabolic and obesity research, supplied in a 20mg lyophilized vial.

• Purity: ≥99%
• Format: Lyophilized powder
• Amount: 20mg per vial
• Storage: Refrigerate upon receipt

Biochemical Profile

• Receptor Targets: GIP receptor (GIPR), GLP-1 receptor (GLP-1R) & Glucagon receptor (GCGR)
• Mechanism: Triple incretin agonist; simultaneous activation of GIPR, GLP-1R, and GCGR via Gαs-coupled signaling
• Half-Life: ~6 days (research models)
• Solubility: Soluble in water at physiological pH

⚠️ Disclaimer: This product is intended for research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified researchers only. Keep out of reach of children.